Edward Hurwitz
QuietNamed in filings at MPM BioVentures
- Board seats filed
- 7
all filings on record
Named in filings at MPM BioVentures
all filings on record
last 24 months
from a verified or cited source
| Arialys Therapeutics | Biotech & pharma | November 2022 | None on file |
| Dyne Therapeutics | Biotech & pharma | August 2020 | Atlas Venture |
| RECODE THERAPEUTICS | Biotech & pharma | March 2020 | Orbimed Asia Partners, Orbimed Genesis, Vida Ventures |
| Protego Biopharma | Biotech & pharma | December 2019 | None on file |
| BioIntervene | Biotech & pharma | March 2019 | None on file |
| Rekindle Therapeutics | Not yet classified | October 2018 | None on file |
| ViewPoint Therapeutics | Biotech & pharma | April 2016 | Clarus |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Edward Hurwitz on the board, based on 6 filed seats with a verified or cited source.
1 more filed seat not yet classified, left out of the shares above.